193 related articles for article (PubMed ID: 8385105)
21. Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation.
Backer JM; Schroeder GG; Kahn CR; Myers MG; Wilden PA; Cahill DA; White MF
J Biol Chem; 1992 Jan; 267(2):1367-74. PubMed ID: 1309768
[TBL] [Abstract][Full Text] [Related]
22. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
23. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
[TBL] [Abstract][Full Text] [Related]
24. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
Jackson JG; White MF; Yee D
J Biol Chem; 1998 Apr; 273(16):9994-10003. PubMed ID: 9545345
[TBL] [Abstract][Full Text] [Related]
25. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade.
Uehara T; Tokumitsu Y; Nomura Y
Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.
Yau L; Lukes H; McDiarmid H; Werner J; Zahradka P
Eur J Biochem; 1999 Dec; 266(3):1147-57. PubMed ID: 10583412
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-I-induced DNA synthesis in insulin-secreting cell line RINm5F is associated with phosphorylation of the insulin-like growth factor-I receptor and the insulin receptor substrate-2.
Zhang Q; Berggren PO; Hansson A; Tally M
J Endocrinol; 1998 Mar; 156(3):573-81. PubMed ID: 9582514
[TBL] [Abstract][Full Text] [Related]
28. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice.
Patti ME; Sun XJ; Bruening JC; Araki E; Lipes MA; White MF; Kahn CR
J Biol Chem; 1995 Oct; 270(42):24670-3. PubMed ID: 7559579
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
Kim B; van Golen CM; Feldman EL
Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916
[TBL] [Abstract][Full Text] [Related]
30. Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation.
Okamoto M; Hayashi T; Kono S; Inoue G; Kubota M; Okamoto M; Kuzuya H; Imura H
Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):327-33. PubMed ID: 8383963
[TBL] [Abstract][Full Text] [Related]
31. Insulin and IGF-I signaling through the insulin receptor substrate 1.
Keller SR; Lamphere L; Lavan BE; Kuhné MR; Lienhard GE
Mol Reprod Dev; 1993 Aug; 35(4):346-51; discussion 351-2. PubMed ID: 8398112
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
Kim B; Leventhal PS; White MF; Feldman EL
Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
[TBL] [Abstract][Full Text] [Related]
33. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
Valverde AM; Teruel T; Lorenzo M; Benito M
Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
35. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
[TBL] [Abstract][Full Text] [Related]
36. Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1.
Yonezawa K; Ueda H; Hara K; Nishida K; Ando A; Chavanieu A; Matsuba H; Shii K; Yokono K; Fukui Y
J Biol Chem; 1992 Dec; 267(36):25958-65. PubMed ID: 1334490
[TBL] [Abstract][Full Text] [Related]
37. Involvement of insulin receptor substrates in epidermal growth factor induced activation of phosphatidylinositol 3-kinase in rat hepatocyte primary culture.
Fujioka T; Ui M
Eur J Biochem; 2001 Jan; 268(1):25-34. PubMed ID: 11121098
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition.
Lee AV; Gooch JL; Oesterreich S; Guler RL; Yee D
Mol Cell Biol; 2000 Mar; 20(5):1489-96. PubMed ID: 10669726
[TBL] [Abstract][Full Text] [Related]
39. Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation.
Greene MW; Garofalo RS
Biochemistry; 2002 Jun; 41(22):7082-91. PubMed ID: 12033942
[TBL] [Abstract][Full Text] [Related]
40. Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells.
Amoui M; Craddock BP; Miller WT
J Endocrinol; 2001 Oct; 171(1):153-62. PubMed ID: 11572799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
